SULT2A1 Antibodies

Santa Cruz Biotechnology offers a broad range of SULT2A1 monoclonal antibodies for research focused on understanding sulfotransferase family 2A member 1 (SULT2A1). SULT2A1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SULT2A1 functions as a key enzyme in the metabolism of steroid hormones and xenobiotics. The sulfation process catalyzed by SULT2A1 regulates biological activity and facilitates the elimination of various compounds from the body. Research has shown SULT2A1 to be particularly active in the liver, where it contributes significantly to drug metabolism. SULT2A1 expression patterns vary across different tissues and developmental stages, making it an interesting target for developmental biology studies. Recent investigations have highlighted SULT2A1's potential involvement in various metabolic disorders. Understanding SULT2A1 activity provides valuable insights into drug development and therapeutic strategies. SULT2A1 research continues to reveal new aspects of metabolic regulation and detoxification pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SULT2A1's role in human health and disease.